Bristol Myers Squibb

Bristol Myers Squibb accounts for 24 tracked companies with verified cap-table data, 24 of which disclose round sizes totalling $3.5B. The median disclosed raise is $135M, and the largest is TORL BioTherapeutics at $450M, ahead of Metagenomi ($300M) and Asher Bio ($215M).

The names that recur most often on these co-invested cap tables are Bristol Myers Squibb (24 companies), Alexandria Venture Investments (7 companies), Leaps by Bayer (3 companies), GV (3 companies), Pfizer Ventures (3 companies), Deep Track Capital (2 companies). By latest disclosed round, the market skews Series B (12), Series A (8), Series C (4).

• Companies tracked: 24
• Disclosed funding total: $3.5B across 24 companies
• Median disclosed raise: $135M
• Largest raise: TORL BioTherapeutics — $450M
• Stage mix: Series B 12 · Series A 8 · Series C 4
• Most recent dated round: 2026-01-12

Best funded Bristol Myers Squibb companies

1. TORL BioTherapeutics — $450M (latest: Series C)
2. Metagenomi — $300M (latest: Series B)
3. Asher Bio — $215M (latest: Series C)
4. Nuvig Therapeutics — $208M (latest: Series B)
5. Attralus — $201M (latest: Series B)
6. ROME Therapeutics — $199M (latest: Series B)
7. Mediar Therapeutics — $181M (latest: Series A)
8. GlycoEra — $179M (latest: Series B)
9. Accent Therapeutics — $178M (latest: Series C)
10. Autobahn Therapeutics — $176M (latest: Series B)
11. Capstan Therapeutics — $165M (latest: Series A)
12. Cour Pharmaceuticals Development — $135M (latest: Series A)
13. Octant Bio — $115M (latest: Series B)
14. Orna Therapeutics — $100M (latest: Series A)
15. Cajal Neuroscience — $96M (latest: Series A)

Bristol Myers Squibb — related firms and companies (56)

• TORL BioTherapeutics
• Metagenomi
• Asher Bio
• Nuvig Therapeutics
• Attralus
• ROME Therapeutics
• Mediar Therapeutics
• GlycoEra
• Clade Therapeutics
• Investors like Vine Ventures
• Investors like Gaingels
• Cour Pharmaceuticals Development
• Investors like SV Angel
• Investors like Bristol Myers Squibb
• Investors like The Westly Group
• Investors like Slow Ventures
• Sapience Therapeutics
• Investors like BoxGroup
• Investors like Founder Collective
• Ratio Therapeutics
• Investors like Draper Associates
• Investors like Maveron
• Capstan Therapeutics
• Investors like Greycroft
• Bristol Myers Squibb portfolio companies 2026
• Investors like True Ventures
• Investors like Floodgate
• Ceptur Therapeutics
• Investors like SOSV
• Investors like FirstMark
• Cajal Neuroscience
• Investors like Venrock
• Investors like F-Prime
• Autobahn Therapeutics
• Investors like Sutter Hill Ventures
• NeoPhore
• Investors like IVP
• Investors like Contour Venture Partners
• Ribon Therapeutics
• Investors like B Capital
• Investors like Shasta Ventures
• Orna Therapeutics
• Investors like Point72 Ventures
• Investors like 137 Ventures
• Accent Therapeutics
• Investors like CAVU Consumer Partners
• Prellis Biologics
• Investors like DCM Ventures
• Investors like Trinity Ventures
• Precede Biosciences
• Investors like Bling Capital
• Investors like Bienville Capital
• Octant Bio
• Investors like Sofinnova Investments
• Companies backed by Bristol Myers Squibb
• Investors like Alexandria Venture Investments

Bristol Myers Squibb alternatives · All research reports